XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders’ Equity (Statement) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Previously Reported
Previously Reported
Common Stock
Previously Reported
Treasury Stock
Previously Reported
Additional Paid-in Capital
Previously Reported
Accumulated Deficit
Revision of Prior Period, Adjustment
Revision of Prior Period, Adjustment
Common Stock
Revision of Prior Period, Adjustment
Treasury Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Accumulated Deficit
Shares outstanding at beginning of period (in shares) at Dec. 31, 2019   20,626,249         3,681,185         16,945,064      
Total stockholders' equity at beginning of period at Dec. 31, 2019 $ 85,302 $ 2 $ 0 $ 158,045 $ (72,745) $ 85,302 $ 36 $ (23,453) $ 181,464 $ (72,745) $ 0 $ (34) $ 23,453 $ (23,419) $ 0
Stock-based compensation expense and vesting of restricted stock units 749     749                      
Net loss (2,409)       (2,409)                    
Shares outstanding at end of period (in shares) at Mar. 31, 2020   20,626,249                          
Total stockholders' equity at end of period at Mar. 31, 2020 83,642 $ 2 0 158,794 (75,154)                    
Shares outstanding at beginning of period (in shares) at Dec. 31, 2020   20,626,249         3,681,185         16,945,064      
Total stockholders' equity at beginning of period at Dec. 31, 2020 83,019 $ 2 0 161,033 (78,016) $ 83,019 $ 36 $ (23,453) $ 184,452 $ (78,016) $ 0 $ (34) $ 23,453 $ (23,419) $ 0
Conversion of convertible promissory note (in shares)   290,563                          
Conversion of convertible promissory note 2,730     2,730                      
Business Combination and PIPE financing (in shares)   12,644,168                          
Business Combination and PIPE financing 94,855 $ 1 (4,445) 99,299                      
Stock-based compensation expense and vesting of restricted stock units 3,498     3,498                      
Net loss (4,997)       (4,997)                    
Shares outstanding at end of period (in shares) at Mar. 31, 2021   33,560,980                          
Total stockholders' equity at end of period at Mar. 31, 2021 $ 179,105 $ 3 $ (4,445) $ 266,560 $ (83,013)